The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Exenatide (marketed as Byetta, Bydureon) is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) medication, belonging to the group of incretin mimetics, approved in April 2005 for the treatment of diabetes mellitus type 2.
The global Exenatide market was valued at US$ 101 million in 2023 and is anticipated to reach US$ 123.7 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
Exenatide is a medication used in the treatment of type 2 diabetes mellitus. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which stimulates insulin secretion and reduces glucagon secretion in a glucose-dependent manner. There are several factors that contribute to the market drive for exenatide: Exenatide has been shown to effectively lower blood glucose levels, improve glycemic control, and reduce HbA1c levels in patients with type 2 diabetes. It is also associated with weight loss, which is beneficial for overweight or obese patients. The medication has a positive impact on cardiovascular health by reducing the risk of myocardial infarction and stroke. As a GLP-1 agonist, exenatide mimics the physiological effects of incretin hormones, which are released in response to food ingestion. It enhances the body's natural response to food by increasing insulin secretion, suppressing glucagon secretion, and delaying gastric emptying. The medication's unique mechanism of action sets it apart from other diabetes medications, and it is considered a valuable treatment option for patients who are not achieving glycemic control with other medications. Exenatide is administered by subcutaneous injection, once or twice daily, and can be self-administered by patients. The medication's convenient dosing schedule and ease of use make it a popular choice among patients and healthcare providers. The prevalence of diabetes is increasing globally, and there is a significant unmet need for effective and well-tolerated treatment options. Exenatide is gaining market acceptance as a result of its proven efficacy, safety, and convenience. The medication is approved for use in several countries, including the United States, Europe, and Japan. Exenatide is protected by patents, which contribute to the medication's market drive by limiting competition and ensuring market exclusivity. The medication's patent protection has helped to maintain its market position and secure its profitability for the pharmaceutical companies that manufacture it.
This report aims to provide a comprehensive presentation of the global market for Exenatide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exenatide.
Report Scope
The Exenatide market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exenatide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exenatide companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Byetta
guangzhou tosun pharmaceutical co. ltd.
Fierce Pharma
MIMS Hong Kong
Segment by Type
Extended-release injectable suspension
Fast release injectable suspension
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exenatide companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Exenatide (marketed as Byetta, Bydureon) is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) medication, belonging to the group of incretin mimetics, approved in April 2005 for the treatment of diabetes mellitus type 2.
The global Exenatide market was valued at US$ 101 million in 2023 and is anticipated to reach US$ 123.7 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
Exenatide is a medication used in the treatment of type 2 diabetes mellitus. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which stimulates insulin secretion and reduces glucagon secretion in a glucose-dependent manner. There are several factors that contribute to the market drive for exenatide: Exenatide has been shown to effectively lower blood glucose levels, improve glycemic control, and reduce HbA1c levels in patients with type 2 diabetes. It is also associated with weight loss, which is beneficial for overweight or obese patients. The medication has a positive impact on cardiovascular health by reducing the risk of myocardial infarction and stroke. As a GLP-1 agonist, exenatide mimics the physiological effects of incretin hormones, which are released in response to food ingestion. It enhances the body's natural response to food by increasing insulin secretion, suppressing glucagon secretion, and delaying gastric emptying. The medication's unique mechanism of action sets it apart from other diabetes medications, and it is considered a valuable treatment option for patients who are not achieving glycemic control with other medications. Exenatide is administered by subcutaneous injection, once or twice daily, and can be self-administered by patients. The medication's convenient dosing schedule and ease of use make it a popular choice among patients and healthcare providers. The prevalence of diabetes is increasing globally, and there is a significant unmet need for effective and well-tolerated treatment options. Exenatide is gaining market acceptance as a result of its proven efficacy, safety, and convenience. The medication is approved for use in several countries, including the United States, Europe, and Japan. Exenatide is protected by patents, which contribute to the medication's market drive by limiting competition and ensuring market exclusivity. The medication's patent protection has helped to maintain its market position and secure its profitability for the pharmaceutical companies that manufacture it.
This report aims to provide a comprehensive presentation of the global market for Exenatide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exenatide.
Report Scope
The Exenatide market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exenatide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exenatide companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Byetta
guangzhou tosun pharmaceutical co. ltd.
Fierce Pharma
MIMS Hong Kong
Segment by Type
Extended-release injectable suspension
Fast release injectable suspension
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exenatide companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exenatide Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Extended-release injectable suspension
1.2.3 Fast release injectable suspension
1.3 Market by Application
1.3.1 Global Exenatide Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exenatide Market Perspective (2019-2030)
2.2 Exenatide Growth Trends by Region
2.2.1 Global Exenatide Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Exenatide Historic Market Size by Region (2019-2024)
2.2.3 Exenatide Forecasted Market Size by Region (2025-2030)
2.3 Exenatide Market Dynamics
2.3.1 Exenatide Industry Trends
2.3.2 Exenatide Market Drivers
2.3.3 Exenatide Market Challenges
2.3.4 Exenatide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exenatide Players by Revenue
3.1.1 Global Top Exenatide Players by Revenue (2019-2024)
3.1.2 Global Exenatide Revenue Market Share by Players (2019-2024)
3.2 Global Exenatide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Exenatide Revenue
3.4 Global Exenatide Market Concentration Ratio
3.4.1 Global Exenatide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exenatide Revenue in 2023
3.5 Exenatide Key Players Head office and Area Served
3.6 Key Players Exenatide Product Solution and Service
3.7 Date of Enter into Exenatide Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exenatide Breakdown Data by Type
4.1 Global Exenatide Historic Market Size by Type (2019-2024)
4.2 Global Exenatide Forecasted Market Size by Type (2025-2030)
5 Exenatide Breakdown Data by Application
5.1 Global Exenatide Historic Market Size by Application (2019-2024)
5.2 Global Exenatide Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Exenatide Market Size (2019-2030)
6.2 North America Exenatide Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Exenatide Market Size by Country (2019-2024)
6.4 North America Exenatide Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exenatide Market Size (2019-2030)
7.2 Europe Exenatide Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Exenatide Market Size by Country (2019-2024)
7.4 Europe Exenatide Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exenatide Market Size (2019-2030)
8.2 Asia-Pacific Exenatide Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Exenatide Market Size by Region (2019-2024)
8.4 Asia-Pacific Exenatide Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exenatide Market Size (2019-2030)
9.2 Latin America Exenatide Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Exenatide Market Size by Country (2019-2024)
9.4 Latin America Exenatide Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exenatide Market Size (2019-2030)
10.2 Middle East & Africa Exenatide Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Exenatide Market Size by Country (2019-2024)
10.4 Middle East & Africa Exenatide Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Exenatide Introduction
11.1.4 AstraZeneca Revenue in Exenatide Business (2019-2024)
11.1.5 AstraZeneca Recent Development
11.2 Byetta
11.2.1 Byetta Company Detail
11.2.2 Byetta Business Overview
11.2.3 Byetta Exenatide Introduction
11.2.4 Byetta Revenue in Exenatide Business (2019-2024)
11.2.5 Byetta Recent Development
11.3 guangzhou tosun pharmaceutical co. ltd.
11.3.1 guangzhou tosun pharmaceutical co. ltd. Company Detail
11.3.2 guangzhou tosun pharmaceutical co. ltd. Business Overview
11.3.3 guangzhou tosun pharmaceutical co. ltd. Exenatide Introduction
11.3.4 guangzhou tosun pharmaceutical co. ltd. Revenue in Exenatide Business (2019-2024)
11.3.5 guangzhou tosun pharmaceutical co. ltd. Recent Development
11.4 Fierce Pharma
11.4.1 Fierce Pharma Company Detail
11.4.2 Fierce Pharma Business Overview
11.4.3 Fierce Pharma Exenatide Introduction
11.4.4 Fierce Pharma Revenue in Exenatide Business (2019-2024)
11.4.5 Fierce Pharma Recent Development
11.5 MIMS Hong Kong
11.5.1 MIMS Hong Kong Company Detail
11.5.2 MIMS Hong Kong Business Overview
11.5.3 MIMS Hong Kong Exenatide Introduction
11.5.4 MIMS Hong Kong Revenue in Exenatide Business (2019-2024)
11.5.5 MIMS Hong Kong Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Exenatide Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Extended-release injectable suspension
Table 3. Key Players of Fast release injectable suspension
Table 4. Global Exenatide Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Exenatide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Exenatide Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Exenatide Market Share by Region (2019-2024)
Table 8. Global Exenatide Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Exenatide Market Share by Region (2025-2030)
Table 10. Exenatide Market Trends
Table 11. Exenatide Market Drivers
Table 12. Exenatide Market Challenges
Table 13. Exenatide Market Restraints
Table 14. Global Exenatide Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Exenatide Market Share by Players (2019-2024)
Table 16. Global Top Exenatide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exenatide as of 2023)
Table 17. Ranking of Global Top Exenatide Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Exenatide Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Exenatide Product Solution and Service
Table 21. Date of Enter into Exenatide Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Exenatide Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Exenatide Revenue Market Share by Type (2019-2024)
Table 25. Global Exenatide Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Exenatide Revenue Market Share by Type (2025-2030)
Table 27. Global Exenatide Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Exenatide Revenue Market Share by Application (2019-2024)
Table 29. Global Exenatide Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Exenatide Revenue Market Share by Application (2025-2030)
Table 31. North America Exenatide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Exenatide Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Exenatide Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Exenatide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Exenatide Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Exenatide Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Exenatide Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Exenatide Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Exenatide Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Exenatide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Exenatide Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Exenatide Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Exenatide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Exenatide Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Exenatide Market Size by Country (2025-2030) & (US$ Million)
Table 46. AstraZeneca Company Detail
Table 47. AstraZeneca Business Overview
Table 48. AstraZeneca Exenatide Product
Table 49. AstraZeneca Revenue in Exenatide Business (2019-2024) & (US$ Million)
Table 50. AstraZeneca Recent Development
Table 51. Byetta Company Detail
Table 52. Byetta Business Overview
Table 53. Byetta Exenatide Product
Table 54. Byetta Revenue in Exenatide Business (2019-2024) & (US$ Million)
Table 55. Byetta Recent Development
Table 56. guangzhou tosun pharmaceutical co. ltd. Company Detail
Table 57. guangzhou tosun pharmaceutical co. ltd. Business Overview
Table 58. guangzhou tosun pharmaceutical co. ltd. Exenatide Product
Table 59. guangzhou tosun pharmaceutical co. ltd. Revenue in Exenatide Business (2019-2024) & (US$ Million)
Table 60. guangzhou tosun pharmaceutical co. ltd. Recent Development
Table 61. Fierce Pharma Company Detail
Table 62. Fierce Pharma Business Overview
Table 63. Fierce Pharma Exenatide Product
Table 64. Fierce Pharma Revenue in Exenatide Business (2019-2024) & (US$ Million)
Table 65. Fierce Pharma Recent Development
Table 66. MIMS Hong Kong Company Detail
Table 67. MIMS Hong Kong Business Overview
Table 68. MIMS Hong Kong Exenatide Product
Table 69. MIMS Hong Kong Revenue in Exenatide Business (2019-2024) & (US$ Million)
Table 70. MIMS Hong Kong Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exenatide Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Exenatide Market Share by Type: 2023 VS 2030
Figure 3. Extended-release injectable suspension Features
Figure 4. Fast release injectable suspension Features
Figure 5. Global Exenatide Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Exenatide Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Drug store Case Studies
Figure 9. Exenatide Report Years Considered
Figure 10. Global Exenatide Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Exenatide Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Exenatide Market Share by Region: 2023 VS 2030
Figure 13. Global Exenatide Market Share by Players in 2023
Figure 14. Global Top Exenatide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exenatide as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Exenatide Revenue in 2023
Figure 16. North America Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Exenatide Market Share by Country (2019-2030)
Figure 18. United States Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Exenatide Market Share by Country (2019-2030)
Figure 22. Germany Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Exenatide Market Share by Region (2019-2030)
Figure 30. China Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Exenatide Market Share by Country (2019-2030)
Figure 38. Mexico Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Exenatide Market Share by Country (2019-2030)
Figure 42. Turkey Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Exenatide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. AstraZeneca Revenue Growth Rate in Exenatide Business (2019-2024)
Figure 45. Byetta Revenue Growth Rate in Exenatide Business (2019-2024)
Figure 46. guangzhou tosun pharmaceutical co. ltd. Revenue Growth Rate in Exenatide Business (2019-2024)
Figure 47. Fierce Pharma Revenue Growth Rate in Exenatide Business (2019-2024)
Figure 48. MIMS Hong Kong Revenue Growth Rate in Exenatide Business (2019-2024)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
